Search Results 291-300 of 16101 for Residual
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
Poster Session: Estrogen receptor expression in residual breast cancer following neoadjuvant chemotherapy. Session time: Monday, June 2, 9 a.m. to noon CDT
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Rochester, MN; La Crosse, WI. The purpose of this study is to determine what kind of ...
To access residual muscle specimens from diagnostic muscle biopsies obtained as part of the routine medical care. The biospecimens will be used to better ...
Identifying minimal residual disease results after combination chemotherapy may help guide future treatment decisions for patients with chronic lymphocytic ...
The study incorporates baseline and follow-up ctDNA assessments to monitor molecular residual disease (MRD) through a tumor-informed WGS-based ctDNA approach ...
Overview. Essential tremor is a nervous system condition, also known as a neurological condition. It causes rhythmic shaking that you can't control.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.